Journal Home
Search for

Volume 35, Issue 1, Pages 67-76 (Spring 2010)


View previous. 12 of 12

Superiority of Equivalent Uniform Dose (EUD)-Based Optimization for Breast and Chest Wall*

Oral presentation at the 49th Annual Meeting of the American Association of Physicists in Medicine, July 2007.

Dimitris N. Mihailidis, Ph.D.Corresponding Author Informationemail address, Brian Plants, M.D., Lloyd Farinash, M.D., Michael Harmon, M.D., Lewis Whaley, D.O., Prem Raja, M.D., Pelagia Tomara, M.S.

Received 10 October 2008; accepted 2 March 2009. published online 18 May 2009.

Abstract 

We investigate whether IMRT optimization based on generalized equivalent uniform dose (gEUD) objectives for organs at risk (OAR) results in superior dosimetric outcomes when compared with multiple dose-volume (DV)–based objectives plans for patients with intact breast and postmastectomy chest wall (CW) cancer. Four separate IMRT plans were prepared for each of the breast and CW cases (10 patients). The first three plans used our standard in-house, physician-selected, DV objectives (phys-plan); gEUD-based objectives for the OARs (gEUD-plan); and multiple, “very stringent,” DV objectives for each OAR and PTV (DV-plan), respectively. The fourth plan was only beam-fluence optimized (FO-plan), without segmentation, which used the same objectives as in the DV-plan. The latter plan was to be used as an “optimum” benchmark without the effects of the segmentation for deliverability. Dosimetric quantities, such as V20Gy for the ipsilateral lung and mean dose (Dmean) for heart, contralateral breast, and contralateral lung were used to evaluate the results. For all patients in this study, we have seen that the gEUD-based plans allow greater sparing of the OARs while maintaining equivalent target coverage. The average ipsilateral lung V20Gy reduced from 22 ± 4.4% for the FO-plan to 18 ± 3% for the gEUD-plan. All other dosimetric quantities shifted towards lower doses for the gEUD-plan. gEUD-based optimization can be used to search for plans of different DVHs with the same gEUDs. The use of gEUD allows selective optimization and reduction of the dose for each OAR and results in a truly individualized treatment plan.

Charleston Radiation Therapy Consultants, Charleston, WV

Corresponding Author InformationReprint requests to: Dimitris Mihailidis, Ph.D., Charleston Radiation Therapy Consultants, 3100 MacCorkle Ave., SE, Suite B-1, Charleston, WV 25304

PII: S0958-3947(09)00010-7

doi:10.1016/j.meddos.2009.03.002


View previous. 12 of 12